Search

everythinglearnresearchcommunity

for

Search:↓

*Acorus calamus* has many medicinal benefits but needs more safety research.

A blood pressure drug, diltiazem, may also help treat influenza.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Early diagnosis and treatment of TPP can prevent complications.

Skin and hair can help us understand organ regeneration, especially how certain stem cells might be used to form new organs.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

17-β-Estradiol applied to the skin stops hair growth, while ICI 182 780 helps hair grow in mice.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Some plants with flavonoids may help treat hair loss and promote hair growth.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Minoxidil treatment increases aorta elasticity and reduces stiffness in aged mice, potentially helping with age-related heart issues.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Hes1 protein is important for hair growth and regeneration, and could be a potential treatment for hair loss.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.